<DOC>
	<DOC>NCT00723268</DOC>
	<brief_summary>The purpose of this study is to determine whether low doses of prednisolone, or colchicine are effective in the treatment of oral aphthae.</brief_summary>
	<brief_title>Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae</brief_title>
	<detailed_description>Treatment of recurrent aphthous stomatitis (RAS) remains, to date, empirical and non-specific. The main goals of therapy are to minimize pain and functional disabilities as well as decrease inflammatory reactions and frequency of recurrences.</detailed_description>
	<mesh_term>Stomatitis, Aphthous</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Confirmation of clinical diagnosis of aphthae Having the experience of oral aphthae at least once in a month Two weeks wash out periods after the last treatment History of any systemic disease Using drugs which affect immune system Pregnancy and breast feeding Aphthous related syndromes</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Oral ulcers</keyword>
</DOC>